The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure

Elias Jabbour, Hagop M. Kantarjian, Hady Ghanem, Susan O’Brien, Alfonso Quintás‐Cardama, Guillermo Garcia‐Manero, Jörge E. Cortes

Clinical Lymphoma Myeloma & Leukemia · 2013 · 23 citations · 25 references

DOIFull text

Open access

Concepts

References

25